MOG antibody-positive paraneoplastic myelopathy in breast carcinoma: the new culprit

This is a preview of subscription content, access via your institution.

Fig. 1


  1. 1.

    Flanagan EP, McKeon A, Lennon VA et al (2011) Paraneoplastic isolated myelopathy: clinical course and neuroimaging clues. Neurology 76(24):2089–2095

    CAS  Article  Google Scholar 

  2. 2.

    Flanagan EP, Keegan BM (2013) Paraneoplastic myelopathy. NeurolClin 31(1):307–318

    Google Scholar 

  3. 3.

    Cherian A, Divya KP, Shetty SC, Kannoth S, Thomas B (2020) Coexistent MOG, NMDAR, CASPR2 antibody positivity: Triumph over the triumvirate. Mult Scler Relat Disord 46:102468

    Article  Google Scholar 

  4. 4.

    Graus F, Delattre JY, Antoine JC et al (2004) Recommended diagnostic criteria for paraneoplastic neurological syndromes. J NeurolNeurosurg Psychiatry 75:1135–1140

    CAS  Article  Google Scholar 

  5. 5.

    Pittock SJ, Lennon VA (2008) Aquaporin-4 autoantibodies in a paraneoplastic context. Arch Neurol 65(5):629–632 (published correction appears in Arch Neurol. 2008 Oct;65(10):1394)

    Article  Google Scholar 

  6. 6.

    Keegan BM, Pittock SJ, Lennon VA (2008) Autoimmune myelopathy associated with collapsin response-mediator protein-5 immunoglobulin G. Ann Neurol 63(4):531–534

    Article  Google Scholar 

Download references



Author information



Corresponding author

Correspondence to K. P. Divya.

Ethics declarations

Conflict of interest

The authors declare that they have no competing interest.

Ethical approval

Ethical approval from the institutional review board was not required for this study.

Informed consent

Formal consent was taken from the patient.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Cherian, A., Shetty, S.C., Divya, K.P. et al. MOG antibody-positive paraneoplastic myelopathy in breast carcinoma: the new culprit. Acta Neurol Belg (2021).

Download citation